Pharmacare not really the answer to lowering drug prices, say industry associations
Health Min. Ginette Petitpas Taylor is tasked with reducing Canadians' high drug prices, but industry stakeholders say it's more complicated than introducing a new national drug plan.
As the House Health Committee studies a national pharmacare program, industry associations representing pharmaceutical companies and private health insurers say although they are not opposed to the plan, they believe the country's high drug costs are the result of ske...
SPONSORED CONTENT
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
